Cas no 790713-33-6 (Pazopanib)

Pazopanib structure
Pazopanib structure
Product Name:Pazopanib
CAS No:790713-33-6
MF:C21H23N7O2S
MW:437.518021821976
CID:842192
PubChem ID:10113978
Update Time:2025-04-19

Pazopanib Chemical and Physical Properties

Names and Identifiers

    • Pazopanib
    • 5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide
    • GW 786034
    • GW-786034
    • CHEBI:71219
    • DSSTox_CID_28659
    • DSSTox_RID_82929
    • GW 78603
    • Pazopanib [INN]
    • pazopanibum
    • UNII-7RN5DR86CK
    • Votrient
    • 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
    • EX-A1241
    • 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide
    • PAZOPANIB [VANDF]
    • 5-(3-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)phenylamino)-2-methylbenzenesulfonamide
    • GW786034
    • HY-10208
    • 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide
    • GW7 86034
    • HMS3244C22
    • Z1541638525
    • Q-101400
    • GW 786034B
    • PAZOPANIB [EMA EPAR]
    • NSC800839
    • 5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
    • AB01273967-02
    • AM20090659
    • MFCD11616589
    • CS-0269
    • DTXSID8048733
    • SW218082-3
    • BCPP000129
    • DTXCID1028659
    • indazolylpyrimidine 13
    • s3012
    • Pazopanib [INN:BAN]
    • AS-11066
    • 7RN5DR86CK
    • PAZOPANIB [MI]
    • Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-
    • BCP01839
    • 790713-33-6
    • Kinome_3790
    • GW780604
    • BCP9001053
    • SCHEMBL588608
    • JMC514632 Compound 13
    • CAS-444731-52-6
    • HSDB 8210
    • HMS3745G05
    • PAZOPANIB [WHO-DD]
    • 444731-52-6
    • 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide
    • Tox21_113174
    • AB01273967_05
    • 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
    • GW-780604
    • 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide
    • CUIHSIWYWATEQL-UHFFFAOYSA-N
    • NSC-800839
    • BD164238
    • NCGC00188865-02
    • BDBM26474
    • FT-0684794
    • A19406
    • AKOS005145819
    • cid_10113978
    • GTPL5698
    • Q7157043
    • AB01273967_06
    • DB06589
    • NCGC00188865-01
    • FT-0659928
    • P-6706
    • NSC752782
    • NSC-752782
    • NCGC00188865-10
    • BRD-K74514084-003-02-7
    • NSC 752782
    • NCGC00188865-03
    • Pazopanib- Bio-X
    • HMS3244C21
    • CCG-265010
    • 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide
    • 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide
    • Tox21_113174_1
    • Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-
    • AC-8522
    • HMS3244D21
    • Pazopanib (free base)
    • AB01273967-01
    • 5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide
    • HMS3656L14
    • NS00070516
    • A839572
    • AR-270/43507999
    • CHEMBL477772
    • EN300-57325
    • 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide
    • SB17290
    • Inchi： 1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)
    • InChI Key： CUIHSIWYWATEQL-UHFFFAOYSA-N
    • SMILES： S(C1C=C(C=CC=1C)NC1=NC=CC(=N1)N(C)C1C=CC2=C(C)N(C)N=C2C=1)(N)(=O)=O

Computed Properties

  • Exact Mass: 437.16339418g/mol
  • Monoisotopic Mass: 437.16339418g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 8
  • Heavy Atom Count: 31
  • Rotatable Bond Count: 5
  • Complexity: 717
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.1
  • Topological Polar Surface Area: 127?2

Pazopanib Related Literature

Related Categories

790713-33-6 (Pazopanib) Related Products

Recommended suppliers
Changzhou Guanjia Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Changzhou Guanjia Chemical Co., Ltd
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd